Form 4 Filing for Bio-Rad Laboratories, Inc.

This filing details several transactions by Rajat Mehta, EVP, GBL Commercial Operations at Bio-Rad Laboratories, Inc. On September 4, 2026, Mr. Mehta acquired 4601 shares of Bio-Rad A Common Stock through the vesting of restricted stock units. Subsequently, on September 5, 2026, he acquired an additional 456 shares and 1370 shares of Bio-Rad A Common Stock, also resulting from the vesting of restricted stock units. On the same day, he disposed of 233 shares and 504 shares of Bio-Rad A Common Stock, with a transaction price of $386.11 per share. The restricted stock units vest over four years, with 25% vesting annually and the remainder in quarterly installments.